Interactions of STAT5b-RARα, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways

Blood

Volumn 99, Issue 8, 2002, Pages 2637-2646

  Dong, Shuo ^a,b   Tweardy, David J ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANE PROTEIN; HYBRID PROTEIN; INTERLEUKIN 6; RETINOIC ACID; RETINOID X RECEPTOR; STAT3 PROTEIN; STAT5B PROTEIN; STAT5B RETINOIC ACID RECEPTOR ALPHA FUSION PROTEIN; TRAM1 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; DNA BINDING PROTEIN; MILK PROTEIN; NUCLEAR RECEPTOR CO REPRESSOR 2; NUCLEAR RECEPTOR CO-REPRESSOR 2; ONCOPROTEIN; REPRESSOR PROTEIN; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ALPHA; STAT3 PROTEIN, HUMAN; STAT5 PROTEIN; STAT5 RARALPHA PROTEIN, HUMAN; STAT5-RARALPHA PROTEIN, HUMAN; STAT5B PROTEIN, HUMAN; STEROID RECEPTOR COACTIVATOR 3; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CARCINOGENESIS; CELL MATURATION; CHROMOSOME 17; CHROMOSOME DELETION; CONTROLLED STUDY; EMBRYO; GENE ACTIVITY; GENE IDENTIFICATION; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; CELL CULTURE; CHEMISTRY; DIMERIZATION; DNA RESPONSIVE ELEMENT; DRUG EFFECT; DRUG INTERACTION; DRUG RESISTANCE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

DIMERIZATION; DNA-BINDING PROTEINS; DRUG INTERACTIONS; DRUG RESISTANCE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MILK PROTEINS; ONCOGENE PROTEINS, FUSION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, RETINOIC ACID; REPRESSOR PROTEINS; RESPONSE ELEMENTS; RETINOID X RECEPTORS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0037088996     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.8.2637     Document Type: Article

References (65)

1. Oncogenic transcription factors in the human acute leukemias
2. Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia
3. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia
4. Acute promyelocytic leukemia
5. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR
6. Breakpoint clusters of the PML gene in acute promyelocytic leukemia: Primary structure of the reciprocal products of the PML-RARA gene in a patient with t(15;17)
7. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion
8. Fusion of retinoic acid receptor alpha to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia
9. Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia
10. The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia
11. STATs and gene regulation
12. Jaks and STATs: Biological implications
13. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response
14. The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (STAT) family
15. The genomic structure and chromosomal localization of the mouse STAT3 gene
16. Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells
17. Distribution of the mammalian Stat gene family in mouse chromosomes
18. STATs in oncogenesis
19. A decade of molecular biology of retinoic acid receptors
20. A transcriptional co-repressor that interacts with nuclear hormone receptors
21. Polarity-specific activities of retinoic acid receptors determined by a co-repressor
22. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300
23. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
24. TRAM-1, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1
25. Role of the histone deacetylase complex in acute promyelocytic leukaemia
26. Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers
27. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL
28. A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation
29. PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors
30. Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein
31. The impact of differential binding of wild-type RARalpha, PML-, PLZF- and NPM-RARalpha fusion proteins towards transcriptional co-activator, RIP-140, on retinoic acid responses in acute promyelocytic leukemia
32. Induction of apoptosis by extracellular ubiquitin in human hematopoietic cells: Possible involvement of STAT3 degradation by proteasome pathway in interleukin 6-dependent hematopoietic cells
33. Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A
34. The significance of tetramerization in promoter recruitment by Stat5
35. DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites
36. Functional association of Nmi with Stat5 and Stat1 in IL-2and IFNgamma-mediated signaling
37. Precise gene fusion by PCR
38. Identification of a novel Stat3 recruitment and activation motif within the granulocyte colony-stimulating factor receptor
39. PMLRAR homodimers: Distinct DNA binding properties and heteromeric interactions with RXR
40. The role of STATs in transcriptional control and their impact on cellular function
41. Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains
42. Formation of PML/RAR alpha high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response
43. Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and co-localize to nuclear bodies
44. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins
45. Stat3 activation is required for cellular transformation by v-src
46. Stat3 activation by Src induces specific gene regulation and is required for cell transformation
47. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses
48. Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation
49. Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation
50. Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity
51. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein
52. Activation of STAT transcription factors in oncogenic tyrosine kinase signaling
53. Stat3 as an oncogene
54. A TELJAK2 fusion protein with constitutive kinase activity in human leukemia
55. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis
56. Constitutive activation of STAT5 by the BCRABL oncogene in chronic myelogenous leukemia
57. Expression of signal transducers and activators of transcription proteins in acute myeloid leukemia blasts
58. Mouse retinoic acid receptor alpha 2 isoform is transcribed from a promoter that contains a retinoic acid response element
59. A retinoic acid response element from the rat CRBPI promoter is activated by an RAR/RXR heterodimer
60. A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR
61. All-trans and 9-cis retinoic acid induction of CRABPII transcription is mediated by RAR-RXR heterodimers bound to DR1 and DR2 repeated motifs
62. Evolutionary-conserved enhancers direct region-specific expression of the murine Hoxa-1 and Hoxa-2 loci in both mice and Drosophila
63. Developmental analysis of the retinoic acid-inducible RAR-beta 2 promoter in transgenic animals
64. Transcriptional activation of the human p21 (WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation